A Disease Registry of Patients With Mantle Cell Lymphoma
Public ClinicalTrials.gov record NCT03816683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients With Mantle Cell Lymphoma Treated With Novel Agents
Study identification
- NCT ID
- NCT03816683
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2019
- Primary completion
- Mar 17, 2024
- Completion
- Mar 17, 2024
- Last update posted
- Nov 13, 2025
2019 – 2024
United States locations
- U.S. sites
- 32
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Montgomery | Alabama | 36101 | — |
| Research Site | Clovis | California | 93611 | — |
| Research Site | Boulder | Colorado | 80303-1385 | — |
| Research Site | Jacksonville | Florida | 32256 | — |
| Research Site | Pensacola | Florida | 32503 | — |
| Research Site | Tampa | Florida | 33612-9497 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Augusta | Georgia | 30912 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Iowa City | Iowa | 52242 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Duluth | Minnesota | 55805 | — |
| Research Site | Saint Louis Park | Minnesota | 55416 | — |
| Research Site | Saint Paul | Minnesota | 55102 | — |
| Research Site | Lincoln | Nebraska | 68510 | — |
| Research Site | Berkeley Heights | New Jersey | 07922 | — |
| Research Site | Hackensack | New Jersey | 07601 | — |
| Research Site | East Syracuse | New York | 13057 | — |
| Research Site | New York | New York | 10022 | — |
| Research Site | Eugene | Oregon | 97401-8122 | — |
| Research Site | Danville | Pennsylvania | 17822 | — |
| Research Site | Philadelphia | Pennsylvania | 19104 | — |
| Research Site | Philadelphia | Pennsylvania | 19111 | — |
| Research Site | Nashville | Tennessee | 37232 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Dallas | Texas | 75390 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Seattle | Washington | 98122 | — |
| Research Site | Seattle | Washington | 98195-9472 | — |
| Research Site | Morgantown | West Virginia | 26506 | — |
| Research Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03816683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03816683 live on ClinicalTrials.gov.